Champions Oncology CSBR
NASDAQ CSBR
$5.01 -0.09 (-1.76%)
As of: Sep 9, 2026 · 3:58 PM EDT

Champions Oncology (CSBR) EV to CFO (2011 - 2026)

Champions Oncology (CSBR) posted EV to CFO of 41.49 for Q2 2026, up 41.2% on a QoQ basis from 70.56 in Q1 2026, and down 421.17% year-over-year from 12.92 in Q2 2025.

Analysis

Champions Oncology (CSBR) EV to CFO (2011 - 2026) Analysis & Trends

Champions Oncology has reported EV to CFO for 16 years, with the latest figure at 41.49 in Q2 2026.

  • On a quarterly basis, EV to CFO fell 421.17% year-over-year to 41.49 in Q2 2026; TTM through Apr 2026 was 18.54, a 254.31% decrease from a year earlier, with the FY2026 full-year figure at 18.54, down 254.31% from the prior year.
  • EV to CFO was 41.49 for Q2 2026 at Champions Oncology, up from 70.56 in the prior quarter.
  • The five-year high for EV to CFO was 300.86 in Q1 2025, with the low at 559.0 in Q3 2022.
  • Average EV to CFO over 5 years is 9.12, with a median of 3.91 recorded in 2023.
  • The sharpest annual moves came in 2024 and 2026: EV to CFO surged 1064.97% in 2024, then plunged 421.17% in 2026.
  • Over 5 years, EV to CFO stood at 25.34 in 2022, then soared by 360.33% to 116.65 in 2023, then slumped by 253.91% to 179.54 in 2024, then surged by 72.22% to 49.87 in 2025, then advanced by 16.81% to 41.49 in 2026.
  • The last three EV to CFO figures came in at 41.49 (Q2 2026), 70.56 (Q1 2026), and 49.87 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn
6 Evotec SE 642.83 Mn 216.96 Mn -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -41.49
Jan 31, 2026 -70.56
Oct 31, 2025 -49.87
Jul 31, 2025 128.08
Apr 30, 2025 12.92
Jan 31, 2025 300.86
Oct 31, 2024 -179.54
Jul 31, 2024 200.07
Apr 30, 2024 -34.86
Jan 31, 2024 -81.04
Oct 31, 2023 116.65
Jul 31, 2023 -20.73
Apr 30, 2023 -81.68
Jan 31, 2023 28.02
Oct 31, 2022 25.34
Jul 31, 2022 -559.00
Apr 30, 2022 119.15
Jan 31, 2022 23.42
Oct 31, 2021 103.47
Jul 31, 2021 630.50